stock
Read Original Source (Finance)

Charles River (CRL) Is Up 11.0% After Raising Adjusted EPS Outlook Amid Divestiture-Driven GAAP Losses – Has The Bull Case Changed?

Charles River (CRL) Is Up 11.0% After Raising Adjusted EPS Outlook Amid Divestiture-Driven GAAP Losses – Has The Bull Case Changed?

In August 2026, Charles River Laboratories International reported second-quarter revenue of US$1,004.08 million, swinging to a small net loss, and simultaneously cut its 2026 GAAP EPS guidance to US$3.05–US$3.35 per share, largely due to losses tied to recent divestitures. Despite these GAAP headwinds, the company exce

In August 2026, Charles River Laboratories International reported second-quarter revenue of US$1,004.08 million, swinging to a small net loss, and simultaneously cut its 2026 GAAP EPS guidance to US$3.05–US$3.35 per share, largely due to losses tied to recent divestitures. Despite these GAAP headwinds, the company exceeded non-GAAP earnings expectations, raised its full-year adjusted EPS outlook, and highlighted strong momentum in its Discovery and Safety Assessment segment, pointing to...